Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The EU Committee for Medicinal Products for Human Use gave a positive opinion on Eli Lilly's oral weight-loss drug Orforglipron, also called Foundayo. Divi's Laboratories shares were in focus, according to the report.
A European Medicines Agency panel issued a positive opinion on Foundayo, also known as orforglipron, for weight management and type 2 diabetes, moving Eli Lilly closer to a European launch.